248 related articles for article (PubMed ID: 24122170)
1. Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity.
Takaishi M; Uchida K; Fujita F; Tominaga M
J Physiol Sci; 2014 Jan; 64(1):47-57. PubMed ID: 24122170
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis determining inhibition/activation of nociceptive receptor TRPA1 protein: a single amino acid dictates species-specific actions of the most potent mammalian TRPA1 antagonist.
Banzawa N; Saito S; Imagawa T; Kashio M; Takahashi K; Tominaga M; Ohta T
J Biol Chem; 2014 Nov; 289(46):31927-31939. PubMed ID: 25271161
[TBL] [Abstract][Full Text] [Related]
3. The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.
Tonello R; Fusi C; Materazzi S; Marone IM; De Logu F; Benemei S; Gonçalves MC; Coppi E; Castro-Junior CJ; Gomez MV; Geppetti P; Ferreira J; Nassini R
Br J Pharmacol; 2017 Jan; 174(1):57-69. PubMed ID: 27759880
[TBL] [Abstract][Full Text] [Related]
4. 1,8-cineole, a TRPM8 agonist, is a novel natural antagonist of human TRPA1.
Takaishi M; Fujita F; Uchida K; Yamamoto S; Sawada Shimizu M; Hatai Uotsu C; Shimizu M; Tominaga M
Mol Pain; 2012 Nov; 8():86. PubMed ID: 23192000
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
Nakao S; Mabuchi M; Wang S; Kogure Y; Shimizu T; Noguchi K; Tanaka A; Dai Y
Bioorg Med Chem Lett; 2017 Jul; 27(14):3167-3172. PubMed ID: 28576617
[TBL] [Abstract][Full Text] [Related]
6. Identification of molecular determinants for a potent mammalian TRPA1 antagonist by utilizing species differences.
Nakatsuka K; Gupta R; Saito S; Banzawa N; Takahashi K; Tominaga M; Ohta T
J Mol Neurosci; 2013 Nov; 51(3):754-62. PubMed ID: 23872983
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of species-specific activation or blockade of TRPA1 channels.
Chen J; Zhang XF; Kort ME; Huth JR; Sun C; Miesbauer LJ; Cassar SC; Neelands T; Scott VE; Moreland RB; Reilly RM; Hajduk PJ; Kym PR; Hutchins CW; Faltynek CR
J Neurosci; 2008 May; 28(19):5063-71. PubMed ID: 18463259
[TBL] [Abstract][Full Text] [Related]
8. Thymol and related alkyl phenols activate the hTRPA1 channel.
Lee SP; Buber MT; Yang Q; Cerne R; Cortés RY; Sprous DG; Bryant RW
Br J Pharmacol; 2008 Apr; 153(8):1739-49. PubMed ID: 18334983
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis for species-specific activation of human TRPA1 protein by protons involves poorly conserved residues within transmembrane domains 5 and 6.
de la Roche J; Eberhardt MJ; Klinger AB; Stanslowsky N; Wegner F; Koppert W; Reeh PW; Lampert A; Fischer MJ; Leffler A
J Biol Chem; 2013 Jul; 288(28):20280-92. PubMed ID: 23709225
[TBL] [Abstract][Full Text] [Related]
10. Primary alcohols activate human TRPA1 channel in a carbon chain length-dependent manner.
Komatsu T; Uchida K; Fujita F; Zhou Y; Tominaga M
Pflugers Arch; 2012 Apr; 463(4):549-59. PubMed ID: 22222967
[TBL] [Abstract][Full Text] [Related]
11. Borneol inhibits TRPA1, a proinflammatory and noxious pain-sensing cation channel.
Sherkheli MA; Schreiner B; Haq R; Werner M; Hatt H
Pak J Pharm Sci; 2015 Jul; 28(4):1357-63. PubMed ID: 26142526
[TBL] [Abstract][Full Text] [Related]
12. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
13. A new tr(i)p to sense pain: TRPA1 channel as a target for novel analgesics.
Cai X
Expert Rev Neurother; 2008 Nov; 8(11):1675-81. PubMed ID: 18986238
[TBL] [Abstract][Full Text] [Related]
14. Methyl p-hydroxybenzoate causes pain sensation through activation of TRPA1 channels.
Fujita F; Moriyama T; Higashi T; Shima A; Tominaga M
Br J Pharmacol; 2007 May; 151(1):153-60. PubMed ID: 17351650
[TBL] [Abstract][Full Text] [Related]
15. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity.
Stueber T; Eberhardt MJ; Hadamitzky C; Jangra A; Schenk S; Dick F; Stoetzer C; Kistner K; Reeh PW; Binshtok AM; Leffler A
Anesthesiology; 2016 May; 124(5):1153-65. PubMed ID: 26859646
[TBL] [Abstract][Full Text] [Related]
16. Identification of natural compound carnosol as a novel TRPA1 receptor agonist.
Zhai C; Liu Q; Zhang Y; Wang S; Zhang Y; Li S; Qiao Y
Molecules; 2014 Nov; 19(11):18733-46. PubMed ID: 25405290
[TBL] [Abstract][Full Text] [Related]
17. Reactivity recognition by TRPA1 channels.
Cebi M; Koert U
Chembiochem; 2007 Jun; 8(9):979-80. PubMed ID: 17492740
[No Abstract] [Full Text] [Related]
18. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.
Chen J; Joshi SK; DiDomenico S; Perner RJ; Mikusa JP; Gauvin DM; Segreti JA; Han P; Zhang XF; Niforatos W; Bianchi BR; Baker SJ; Zhong C; Simler GH; McDonald HA; Schmidt RG; McGaraughty SP; Chu KL; Faltynek CR; Kort ME; Reilly RM; Kym PR
Pain; 2011 May; 152(5):1165-1172. PubMed ID: 21402443
[TBL] [Abstract][Full Text] [Related]
20. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
